Rusakiewicz, S., Dodi, I.A., Loconto, J., Travers, P.J. and Madrigal, J.A., 2004. Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo? Blood Cells Molecules and Diseases, 33 (3), p. 191. ISSN 1079-9796
Full text not available from this repository.Item Type: | Journal article |
---|---|
Publication Title: | Blood Cells Molecules and Diseases |
Creators: | Rusakiewicz, S., Dodi, I.A., Loconto, J., Travers, P.J. and Madrigal, J.A. |
Date: | 2004 |
Volume: | 33 |
Number: | 3 |
ISSN: | 1079-9796 |
Divisions: | Schools > School of Science and Technology |
Record created by: | EPrints Services |
Date Added: | 09 Oct 2015 10:06 |
Last Modified: | 19 Oct 2015 14:27 |
URI: | https://irep.ntu.ac.uk/id/eprint/7819 |
Actions (login required)
![]() |
Edit View |
Views
Views per month over past year
Downloads
Downloads per month over past year